20/20 Biolabs, Inc. research brief
CIK 1139685
Generated Nov. 18, 2026, 7:59 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: GAITHERSBURG Maryland. Reported legal jurisdiction: Delaware. These do not establish investor residence or where funds were deployed.
- Feb. 26, 2025 · D · 0001786236-25-000007 · Source evidence
Reported offering amount: 3000000 USD. Reported amount sold: 70000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “20/20 Biolabs, Inc. research brief,” CIK 1139685, retrieved Nov. 18, 2026, 7:59 a.m.. Cite the specific accessions used. No amounts have been summed.